首页> 外文期刊>Saudi Pharmaceutical Journal >Linseed hydrogel based floating drug delivery system for fluoroquinolone antibiotics: Design, in vitro drug release and in vivo real-time floating detection
【24h】

Linseed hydrogel based floating drug delivery system for fluoroquinolone antibiotics: Design, in vitro drug release and in vivo real-time floating detection

机译:基于亚麻籽水凝胶的氟喹啉抗生素浮动药物输送系统:设计,体外药物释放和体内实时浮动检测

获取原文
           

摘要

Herein, we designed a novel gastroretentive drug delivery system as floating matrix tablets based on a polysaccharide material from linseeds ( Linum usitatissimum L.) for fluoroquinolone antibiotics. A number of formulations were designed with a combination of linseed hydrogel (LSH) and different excipients to obtain a desired sustained release profile of moxifloxacin. The drug release study was performed basically at pH 1.2. However, the tablet may pass through the stomach to intestine due to certain reasons then it also offered sustained drug release at intestinal pH 4.5, 6.8 and 7.4, as well. Results indicated that sustained moxifloxacin release was directly proportional to the concentration of LSH and the release of drug followed non-Fickian diffusion. SEM of the tablets indicated porous nature of LSH with elongated channels which contributed to the swelling of the tablet and then facilitated the discharge of moxifloxacin from the core of the tablet. In vivo X-ray study was performed to assess disintegration and real-time floating of tablet that confirmed its presence for 6?h in the stomach. These findings indicated that LSH can be used to develop novel gastroretentive sustained release drug delivery systems with the double advantage of sustained drug release at all pH of GIT.
机译:在此,我们设计了一种基于来自亚麻籽(Linum Usitatissimumlimumlimum L.)的多糖材料的新型胃膜引入药物输送系统,用于氟喹诺酮抗生素。设计了许多配方,其具有亚麻籽水凝胶(LSH)和不同赋形剂的组合,以获得Moxifloxacin的所需持续释放曲线。药物释放研究基本上在pH 1.2处进行。然而,由于某些原因,片剂可以通过胃至肠道,然后它也在肠道pH 4.5,6.8和7.4时提供持续的药物释放。结果表明,持续的莫西沙星释放与LSH的浓度成正比,药物释放遵循非Fickian扩散。片剂的SEM表明LSH的多孔性质,带有细长通道,其有助于片剂的肿胀,然后从片剂的核心中促进莫西他素的排出。在体内X射线研究中进行了评估崩解和实时漂浮的片剂,其在胃中证实了6μl的存在。这些发现表明,LSH可用于开发新的胃激活持续释放药物递送系统,其在所有pH下持续的药物释放的双重优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号